Cross-clade ultrasensitive PCR-based assays to measure HIV persistence in large-cohort studies. - Wikidata - wikimedia - TriplyDB

Cross-clade ultrasensitive PCR-based assays to measure HIV persistence in large-cohort studies.

Cross-clade ultrasensitive PCR-based assays to measure HIV persistence in large-cohort studies.

http://www.wikidata.org/entity/Q34593784

about

Loss of Function of Intestinal IL-17 and IL-22 Producing Cells Contributes to Inflammation and Viral Persistence in SIV-Infected Rhesus Macaques Are T cells the only HIV-1 reservoir?DNA/MVA Vaccination of HIV-1 Infected Participants with Viral Suppression on Antiretroviral Therapy, followed by Treatment Interruption: Elicitation of Immune Responses without Control of Re-Emergent Virus Human Galectin-9 Is a Potent Mediator of HIV Transcription and Reactivation A Novel Assay to Measure the Magnitude of the Inducible Viral Reservoir in HIV-infected Individuals CD4+ T Cells Expressing PD-1, TIGIT and LAG-3 Contribute to HIV Persistence during ART.Anti-HIV Antibody Responses and the HIV Reservoir Size during Antiretroviral Therapy Single-Cell Characterization of Viral Translation-Competent Reservoirs in HIV-Infected Individuals Interleukin-21 combined with ART reduces inflammation and viral reservoir in SIV-infected macaques Markers of HIV reservoir size and immune activation after treatment in acute HIV infection with and without raltegravir and maraviroc intensification.Measuring the latent reservoir in vivo.In Vitro Reactivation of Replication-Competent and Infectious HIV-1 by Histone Deacetylase Inhibitors.Towards a scalable HIV cure research agenda: the role of co-infections.Virological and immunological characteristics of HIV-infected individuals at the earliest stage of infection Persistence of integrated HIV DNA in CXCR3 + CCR6 + memory CD4+ T cells in HIV-infected individuals on antiretroviral therapy.Initiation of antiretroviral therapy before detection of colonic infiltration by HIV reduces viral reservoirs, inflammation and immune activation.HIV DNA Set Point is Rapidly Established in Acute HIV Infection and Dramatically Reduced by Early ART.HIV integration sites in latently infected cell lines: evidence of ongoing replication.Association of Arterial and Lymph Node Inflammation With Distinct Inflammatory Pathways in Human Immunodeficiency Virus Infection.Delayed differentiation of potent effector CD8+ T cells reducing viremia and reservoir seeding in acute HIV infection.Total HIV-1 DNA, a Marker of Viral Reservoir Dynamics with Clinical Implications.HIV-1 persistent viremia is frequently followed by episodes of low-level viremia.Strategies to limit immune-activation in HIV patients.A Critical Review of the Evidence Concerning the HIV Latency Reversing Effect of Disulfiram, the Possible Explanations for Its Inability to Reduce the Size of the Latent Reservoir In Vivo, and the Caveats Associated with Its Use in Practice.RNA flow cytometric FISH for investigations into HIV immunology, vaccination and cure strategies.Multiparametric characterization of rare HIV-infected cells using an RNA-flow FISH technique.The TLR9 agonist MGN1703 triggers a potent type I interferon response in the sigmoid colon.Novel assay reveals a large, inducible, replication-competent HIV-1 reservoir in resting CD4+ T cells.Human Immunodeficiency Virus Persistence and T-Cell Activation in Blood, Rectal, and Lymph Node Tissue in Human Immunodeficiency Virus-Infected Individuals Receiving Suppressive Antiretroviral Therapy.PD-1(+) and follicular helper T cells are responsible for persistent HIV-1 transcription in treated aviremic individuals.TZA: a novel assay for measuring the latent HIV-1 reservoir.The Oncolytic Virus MG1 Targets and Eliminates Cells Latently Infected With HIV-1: Implications for an HIV Cure.HIV-1 persistence following extremely early initiation of antiretroviral therapy (ART) during acute HIV-1 infection: An observational study.Identification of Genetically Intact HIV-1 Proviruses in Specific CD4+ T Cells from Effectively Treated Participants.Clinical Relevance of Total HIV DNA in Peripheral Blood Mononuclear Cell Compartments as a Biomarker of HIV-Associated Neurocognitive Disorders (HAND).Acute Retroviral Syndrome is Associated with High Viral Burden, CD4 Depletion, and Immune Activation in Systemic and Tissue Compartments.Extensive virologic and immunologic characterization in an HIV-infected individual following allogeneic stem cell transplant and analytic cessation of antiretroviral therapy: A case study.Tools for Visualizing HIV in Cure Research.Inducible HIV RNA transcription assays to measure HIV persistence: pros and cons of a compromise.Single-molecule techniques to quantify and genetically characterise persistent HIV.

P2860

Q27316093-0DDAFF73-C34C-4CD1-B2C5-2C93829A35C6 Q28078850-28C014B9-A511-44B4-B8C7-D0176E64550C Q28554534-8CC2ECFC-C221-4121-BAA4-99AFE0592F0B Q36037844-EFA7D122-535F-478D-B603-4597A6CBB9C1 Q36038655-654BA89C-C2AC-4F75-A235-2EDD9FBE016B Q36077348-8A7EC4F0-E909-40A2-8627-DEAAA39CCC7C Q36092497-C8FEAA4E-AF59-430B-8351-EC4F92FE1DFE Q36108518-BD4A7EDA-FE57-4413-AD04-0FAF81D293AC Q36335882-06060DCE-E576-4398-8781-DE27CCFC4F8E Q36509593-554586C8-6790-4117-B035-07B6ED066515 Q36515110-5E1B5D9C-1438-445F-BCD5-D33CF69A91E9 Q36523946-6707B5D2-DBB1-4473-A340-6CBDDB1A29C1 Q36540033-7D3B67C3-5CFB-41DC-88B6-C9C639D914F2 Q36581887-7A82B92D-C2B2-4C49-89F8-09C1E1B06898 Q36957851-89101871-2523-42F1-BC34-74B695347496 Q37262786-4E4810D0-E749-41FC-B364-475779D71C83 Q37309464-BAD8FC53-0F67-4C28-867B-BAE603E0F1BC Q37586737-8614376D-1651-4055-BF13-AACAE93B70BC Q37643812-6766953F-7F2D-422A-BDCE-17C4C41B8F0D Q38433251-F00961AA-323D-44EE-AE90-2E259665E59E Q38936786-FD448694-AAA2-4F48-9A21-969C002A39F7 Q38951030-E294C3F9-5EAF-4720-A750-94DC68EC1508 Q38985926-37746911-3CD3-437E-9400-72E3FCD3E45D Q39279515-56C212D5-3AB5-42D5-BB32-785992C8EAF0 Q40053205-FD0438A9-07A9-460C-8F64-18F607B0F7AA Q40054042-A1E1A27D-3736-46F5-B61A-7B227904E371 Q40098403-DCB6F4F4-BBE2-43B7-8A4B-7BAD74712DFE Q40182056-0951CB6C-E492-4D27-8279-2900110BC489 Q40222958-A99F826D-A537-4049-B49C-9B00318C591D Q40653907-BF11278B-0C42-4ABC-AF94-8D00A4706E12 Q41995271-5306A99A-AF3E-4299-9786-1C5F154A5F23 Q45323510-513A1C4B-4775-4927-9CD8-5A513947769F Q45954015-38C6D847-71E8-4C6B-99CB-FADA9C58A3C5 Q46281767-EF1D473A-482A-4690-A645-C5969813AB0C Q46531545-16791F82-E325-4DE3-A637-1246BA841DF8 Q46668682-619F5C9F-0698-47B7-85FF-2DE78BB7CEBC Q46971270-293A9930-00C7-45A3-BD5C-AA0A282E64DA Q47548551-852806AE-23AB-42C5-924F-FFCE9087B82F Q47552344-63E01279-5AFD-4361-97D9-C179E58BC655 Q47556373-93EF1037-6571-46C8-81CA-1C384EFBF23A

P2860

Cross-clade ultrasensitive PCR-based assays to measure HIV persistence in large-cohort studies.

http://www.wikidata.org/entity/Q34593784

description

2014 nî lūn-bûn

@nan

2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Cross-clade ultrasensitive PCR ...... tence in large-cohort studies.

@ast

Cross-clade ultrasensitive PCR ...... tence in large-cohort studies.

@en

Cross-clade ultrasensitive PCR ...... tence in large-cohort studies.

@nl

type

label

Cross-clade ultrasensitive PCR ...... tence in large-cohort studies.

@ast

Cross-clade ultrasensitive PCR ...... tence in large-cohort studies.

@en

Cross-clade ultrasensitive PCR ...... tence in large-cohort studies.

@nl

prefLabel

Cross-clade ultrasensitive PCR ...... tence in large-cohort studies.

@ast

Cross-clade ultrasensitive PCR ...... tence in large-cohort studies.

@en

Cross-clade ultrasensitive PCR ...... tence in large-cohort studies.

@nl

P1433

Q34593784-89BD7098-63F5-4ECF-8256-F0A0D0617977

P1476

Q34593784-63DCF6C9-3AD8-4BBE-97BA-88BA94A478C1

P2093

Q34593784-21BF0A27-5FDF-40D0-94CD-AA4676D44721

Q34593784-2E4636A3-62D5-4E18-A4DF-94C3705CCD76

Q34593784-4D3D6F75-0723-4996-AFC9-2B80E7A15FE1

Q34593784-660CFEE3-AF78-4183-9AD5-65B9B91BB329

Q34593784-827D9F17-B1E3-48F4-8C9F-5B3CC91B5722

Q34593784-87BE38D9-8548-461B-A77D-641B2A9608A0

Q34593784-8D585288-A16F-4D60-BC2F-F7536982F6BE

Q34593784-F9254A60-17E0-42ED-A13A-E26145B8A423

P2860

Q34593784-04845B4C-9DDE-4A9C-AD47-AF11632067C4

Q34593784-08594254-C096-4A78-AA06-C4AA946A5FE5

Q34593784-173B41E8-4398-4949-AD1C-35B09514EE3A

Q34593784-1AC1EAA6-B83F-4CC2-8E99-698AAD7B2AA6

Q34593784-2B84CF72-C7B6-4BC9-8F65-304AE8304C45

Q34593784-36293757-D29F-48DC-8BD2-FAE0812944EA

Q34593784-3756169F-A80D-4C91-B7A0-139FD2191E58

Q34593784-3AA95C04-2ED9-4689-A49E-08A4DA5B6A13

Q34593784-3B85F5B6-DDFB-43BA-B9E9-9469719C429D

Q34593784-42616722-7224-4B10-B18E-A9045B560083

P304

Q34593784-F83BA21A-E972-491F-BB25-62B869A45E2A

P31

Q34593784-8E03452A-0A4F-4166-8664-1B9350724577

P356

Q34593784-5EABF8C4-0C77-4AE5-9740-D60A439EA454

P407

Q34593784-4706D2E9-9182-41F4-8B47-16F87C133862

P433

Q34593784-E33C7CDB-6042-4948-B979-9D802AD07234

P478

Q34593784-E2D260B1-8C50-4A5F-B5D1-194C611CEF40

P50

Q34593784-0A094227-6E5D-44BA-BB60-EE8423E98160

Q34593784-2C12B466-386C-4582-9EB4-B1842DA87506

Q34593784-F36BBC27-522F-4CC7-9305-8C3367EF2419

Q34593784-F87C3C71-10BE-4657-8866-E6E6AEA1ECE8

P577

Q34593784-F633C2A3-3380-4208-A894-0E8CF0FCBE4E

P5875

Q34593784-3B425507-E505-4493-9994-AB3049CF50A8

P698

Q34593784-3BB98834-AD8A-4C37-8D98-F9D2F10EA6CD

P932

Q34593784-F32830CE-B8F7-493A-A34D-3F1ED2FDD7FE

P356

P1433

Journal of Virology

P1476

Cross-clade ultrasensitive PCR ...... tence in large-cohort studies.

@en

P2093

Amanda McNulty

http://www.w3.org/2001/XMLSchema#string

Claire Vandergeeten

http://www.w3.org/2001/XMLSchema#string

Esther Merlini

http://www.w3.org/2001/XMLSchema#string

Mariam B Lawani

http://www.w3.org/2001/XMLSchema#string

Moti Ramgopal

http://www.w3.org/2001/XMLSchema#string

Rémi Fromentin

http://www.w3.org/2001/XMLSchema#string

Sandrina DaFonseca

http://www.w3.org/2001/XMLSchema#string

Wendy Bakeman

http://www.w3.org/2001/XMLSchema#string

P2860

Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy

Deep molecular characterization of HIV-1 dynamics under suppressive HAART

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy

Recovery of replication-competent HIV despite prolonged suppression of plasma viremia

HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation

HIV-infected individuals receiving effective antiviral therapy for extended periods of time continually replenish their viral reservoir.

Effect of raltegravir-containing intensification on HIV burden and T-cell activation in multiple gut sites of HIV-positive adults on suppressive antiretroviral therapy

Comparative analysis of measures of viral reservoirs in HIV-1 eradication studies

Towards an HIV cure: a global scientific strategy

P304

12385-12396

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/JVI.00609-14

http://www.w3.org/2001/XMLSchema#string

P407

P433

21

http://www.w3.org/2001/XMLSchema#string

P478

88

http://www.w3.org/2001/XMLSchema#string

P50

Nicolas Chomont

Jintanat Ananworanich

P577

2014-08-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

264797732

http://www.w3.org/2001/XMLSchema#string

P698

25122785

http://www.w3.org/2001/XMLSchema#string

P932

4248919

http://www.w3.org/2001/XMLSchema#string